Want to take quizzes and track your credits?
Is vigorous exercise and change in exercise associated with a reduction in mortality in adult survivors of childhood cancer?
In this cohort analysis using a questionnaire after a median follow-up of 10 years among 15 450 adult survivors of childhood cancer, there was a significant inverse association across quartiles of exercise and all-cause mortality after adjustment for chronic health conditions and treatment exposures. Increased exercise over 8 years was associated with a 40% reduction in all-cause mortality rate compared with maintenance of low exercise.
Vigorous exercise in early adulthood and increased exercise over 8 years is associated with lower risk of mortality in adult survivors of childhood cancer.
Adult survivors of childhood cancer are at excess risk for mortality compared with the general population. Whether exercise attenuates this risk is not known.
To examine the association between vigorous exercise and change in exercise with mortality in adult survivors of childhood cancer.
Design, Setting, and Participants
Multicenter cohort analysis among 15 450 adult cancer survivors diagnosed before age 21 years from pediatric tertiary hospitals in the United States and Canada between 1970 and 1999 enrolled in the Childhood Cancer Survivor Study, with follow-up through December 31, 2013.
Self-reported vigorous exercise in metabolic equivalent task (MET) hours per week. The association between vigorous exercise and change in vigorous exercise and cause-specific mortality was assessed using multivariable piecewise exponential regression analysis to estimate rate ratios.
Main Outcomes and Measures
The primary outcome was all-cause mortality. Secondary end points were cause-specific mortality (recurrence/progression of primary malignant neoplasm and health-related mortality). Outcomes were assessed via the National Death Index.
The 15 450 survivors had a median age at interview of 25.9 years (interquartile range [IQR], 9.5 years) and were 52.8% male. During a median follow-up of 9.6 years (IQR, 15.5 years), 1063 deaths (811 health-related, 120 recurrence/progression of primary cancer, 132 external/unknown causes) were documented. At 15 years, the cumulative incidence of all-cause mortality was 11.7% (95% CI, 10.6%-12.8%) for those who exercised 0 MET-h/wk, 8.6% (95% CI, 7.4%-9.7%) for 3 to 6 MET-h/wk, 7.4% (95% CI, 6.2%-8.6%) for 9 to 12 MET-h/wk, and 8.0% (95% CI, 6.5%-9.5%) for 15 to 21 MET-h/wk (P < .001). There was a significant inverse association across quartiles of exercise and all-cause mortality after adjusting for chronic health conditions and treatment exposures (P = .02 for trend). Among a subset of 5689 survivors, increased exercise (mean [SD], 7.9 [4.4] MET-h/wk) over an 8-year period was associated with a 40% reduction in all-cause mortality rate compared with maintenance of low exercise (rate ratio, 0.60; 95% CI, 0.44-0.82; P = .001).
Conclusions and Relevance
Vigorous exercise in early adulthood and increased exercise over 8 years was associated with lower risk of mortality in adult survivors of childhood cancer.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Accepted for Publication: April 22, 2018.
Corresponding Author: Lee W. Jones, PhD, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (email@example.com).
Published Online: June 3, 2018. doi:10.1001/jamaoncol.2018.2254
Author Contributions: Drs Scott and Jones had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Scott, Nathan, Gibson, Nilsen, Oeffinger, Ness, Armstrong, Jones.
Acquisition, analysis, or interpretation of data: Scott, Li, Liu, Yasui, Leisenring, Gibson, Amenian, Oeffinger, Ness, Adams, Robison, Armstrong, Jones.
Drafting of the manuscript: Scott, Li, Liu, Adams, Armstrong, Jones.
Critical revision of the manuscript for important intellectual content: Scott, Yasui, Leisenring, Nathan, Gibson, Amenian, Nilsen, Oeffinger, Ness, Adams, Robison, Armstrong, Jones.
Statistical analysis: Li, Liu, Yasui.
Obtained funding: Robison, Armstrong.
Administrative, technical, or material support: Scott, Leisenring, Nilsen, Oeffinger, Adams, Armstrong.
Study supervision: Leisenring.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was supported by the National Cancer Institute (CA55727, Dr Armstrong. Armstrong, Principal Investigator). Support to St Jude Children’s Research Hospital was also provided by the Cancer Center Support (CORE) grant (CA21765, C. Roberts, Principal Investigator) and the American Lebanese-Syrian Associated Charities (ALSAC). Dr Jones is supported by grants from the National Cancer Institute. Drs Scott, Nilsen, Adams, and Jones are supported by AKTIV Against Cancer, and the Kavli Trust.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Meeting Presentation: This work was presented at the American Society of Clinical Oncology Annual Meeting; June 3, 2018; Chicago, Illinois.
You currently have no searches saved.